U.K. National Institute of Health Research has launched a really big project (£4 million funded) to test the efficiency of VR in mental health therapy. This project is called “gameChange” and it evolves many partners (both private and public). In particular, it will test VR products of Oxford VR start-up. The first large-scale trial on psychosis patients will bring robust results on VR efficiency next year according to Oxford VR CEO and allows clinicians to use it more widely.
Healthtech startup Oxford VR has teamed up with gameChange, a £4 million project funded by U.K. National Institute of Health Research, to test the technology and advance its roll out across the National Health Service (NHS). A research team led by Daniel Freeman, professor of psychology at the University of Oxford, will analyze the effectiveness of the technology and produce a commissioning case for VR therapy to be used by the NHS nationwide.